DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment


Population Health Homepage

New research finds brain MR study groups don't reflect U.S. population demographics This must change for large, multicenter studies

European Society of Radiology calls for diagnostics to be better represented in value-based care Diagnosis 'is the basis for any treatment decision'

What would Graham-Cassidy mean for the medical equipment industry? Eliminating the medical device tax, but also fewer insured patients

Low-level ionizing radiation less of a health risk than obesity: study Research aimed at non-medical audience, to 'facilitate a better quality' debate

Premier and UVA Health System enter multi-year strategic partnership Goal to drive enterprise-wide improvements in quality and costs

Global population health management market to exceed $28 billion in 2021 Value-based care is a core driver

Study proposes health care model for rural communities Emergency departments should connect patients to primary care doctors

GE Healthcare acquires consulting firm Novia Strategies Company helped hospitals save hundreds of millions of dollars

Handheld scanner for diagnosing heart disease under development in EU Could drastically reduce the cost for standard approaches

Canadian researchers find a more cost-effective approach to CT lung cancer screening Involves smoking cessation initiatives

Osteoporosis drugs not taken by many who need them: reports

by Thomas Dworetzky , Contributing Reporter
Fear and a lack of awareness in many older adults that they have the bone-weakening disease osteoporosis has led to a growing public health concern by leading medical organizations.

In a joint statement, the American Society for Bone and Mineral Research, National Osteoporosis Foundation and National Bone Health Alliance, announced their concerns.

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras

“Untreated osteoporosis is a public health crisis. Many of us see firsthand the ravages of this disease every day - pain, fractures, loss of mobility and independence, and diminished quality of life,” said Dr. Douglas P. Kiel, ASBMR president and director of the Musculoskeletal Research Center and Senior Scientist for the Institute for Aging Research at Hebrew SeniorLife. “These results build on mounting evidence that identifying and treating patients after the first fracture is crucial to preventing suffering.”

Their statement highlighted recent findings in an Icelandic study that “the fracture risk jumps three-fold after the first fracture.”

“This new information makes it more important than ever that physicians and health care providers take immediate steps to evaluate and treat patients who have sustained an osteoporotic fracture,” said Dr. Robert F. Gagel, Professor of Medicine, MD Anderson Cancer Center, NOF President and NBHA Co-Chair. “At present, only 26 percent of patients who sustain their first osteoporotic fracture are evaluated and treated, putting large numbers of patients at risk for subsequent life altering and preventable fractures – a travesty we must work to fix.”

Several other recent reports highlight this looming health care issue.

One long-range study determined that there is an alarming drop in the number of people with osteoporosis taking medications that effectively combat the condition. “Oral bisphosphonate use declined by greater than 50 percent between 2008 and 2012 after increasing use for more than a decade,” according to a 2015 report in the Journal of Bone and Mineral Research (JBMR).

The main reason is fear. “Ninety percent of patients, when you talk to them about starting one of these drugs, won’t go on,” Dr. Paul D. Miller, medical director of the Colorado Center for Bone Research, a medical practice in Lakewood told the New York Times. “Ninety percent who are on the drugs want to come off. The fear factor is huge.”

This is despite the fact that the worst side-effects of the mainstay medications – such as alendronate, ibandronate, risedronate and zoledronate – are rare. Just 40 in every 100,000 patients have broken a thigh bone, one such complication. Only one in that number will experience necrosis in their jaw, another rare side-effect.
  Pages: 1 - 2 >>

Population Health Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2017, Inc.